This week, Nicox’s blepharitis drug shows promise, a novel stem cell-based therapy for geographic atrophy heads to clinical trials and a mother-daughter reindeer duo undergo cataract surgery. Source: AAO
The authors of this prospective trial evaluated the benefits of adding trabeculectomy during phacoemulsification in patients with primary angle-closure glaucoma. Source: AAO
In this prospective analysis, swept source OCTA was used to study the prevalence, incidence and natural history of subclinical macular neovascularization (MNV). Source: AAO
This retrospective study assessed whether the introduction of corneal collagen crosslinking (CXL) in Canada affected the number of corneal transplants performed for keratoconus. Source: AAO
In this study, investigators developed and tested a novel multiplex PCR test (Strip PCR) for 24 common ocular infectious-disease pathogens. Source: AAO
From negative dysphotopsia to tonometry disinfection, here’s a look at the year’s most-viewed 1-Minute Videos, surgical videos and interviews. Source: AAO
From brolucizumab to atropine for myopia, here’s a look at the year’s most-viewed clinical news stories and Editors’ Choice coverage. Source: AAO
In this phase 3 trial, investigators evaluated the efficacy and safety of satralizumab as adjunct therapy for patients with neuromyelitis optica spectrum disorder (NMOSD). Source: AAO
This randomized controlled trial examined the effects of botulinum toxin type A on postoperative hypertrophic scarring of the medial canthal area. Source: AAO
An FDA advisory committee unanimously backed teprotumumab as the first nonsurgical treatment for thyroid eye disease, according to a press release by Horizon Therapeutics. Source: AAO